These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9391687)

  • 1. Agranulocytosis induced by vancomycin or ticarcillin/clavulanate.
    Mandl DL; Garrison MW; Palpant SD
    Ann Pharmacother; 1997 Nov; 31(11):1321-4. PubMed ID: 9391687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
    Shenep JL; Hughes WT; Roberson PK; Blankenship KR; Baker DK; Meyer WH; Gigliotti F; Sixbey JW; Santana VM; Feldman S
    N Engl J Med; 1988 Oct; 319(16):1053-8. PubMed ID: 3050517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin-induced neutropenia during treatment of osteomyelitis in an outpatient.
    Henry K; Steinberg I; Crossley KB
    Drug Intell Clin Pharm; 1986 Oct; 20(10):783-5. PubMed ID: 3769768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-induced neutropenia.
    Koo KB; Bachand RL; Chow AW
    Drug Intell Clin Pharm; 1986 Oct; 20(10):780-2. PubMed ID: 3769767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutropenia associated with beta-lactam antibiotics.
    Kirkwood CF; Smith LL; Rustagi PK; Schentag JJ
    Clin Pharm; 1983; 2(6):569-78. PubMed ID: 6653059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure.
    Duff JM; Moreb JS; Muwalla F
    Ann Pharmacother; 2012 Jan; 46(1):e1. PubMed ID: 22170976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin.
    Hsiao SH; Chang CM; Tsai JC; Lin CY; Liao LH; Lin WL; Wu TJ
    Ann Pharmacother; 2007 May; 41(5):891-4. PubMed ID: 17426073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients.
    Naseem A; Hussain Y; Ahmad B; Aziz MT; Ahmad M; Hameed H
    J Pak Med Assoc; 2011 Jan; 61(1):18-22. PubMed ID: 22368896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
    Brion JP; Bru JP; Michallet M; Corron B; Fauconnier J
    Presse Med; 1988 Oct; 17(37):1964-7. PubMed ID: 2973597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticarcillin-induced neutropenia corroborated by in vitro CFU-C toxicity.
    Irvine AE; Morris TC; Kelly GJ; McCracken N
    Acta Haematol; 1983; 70(6):364-8. PubMed ID: 6417960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticarcillin/clavulanate versus imipenem/cilistatin for the treatment of infections associated with gangrenous and perforated appendicitis.
    Allo MD; Bennion RS; Kathir K; Thompson JE; Lentz M; Meute M; Finegold SM
    Am Surg; 1999 Feb; 65(2):99-104. PubMed ID: 9926739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of three types of empirical antibiotherapy in patients with febrile neutropenia: imipenem-cilastatin versus ceftazidime-vancomycin versus ticarcillin-amikacin-vancomycin].
    Bosseray A; Nicolini F; Brion JP; Michallet M; Hollard D; Stahl JP; Micoud M
    Pathol Biol (Paris); 1992 Oct; 40(8):797-804. PubMed ID: 1484739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-induced neutropenia.
    Mackett RL; Guay DR
    Can Med Assoc J; 1985 Jan; 132(1):39-40. PubMed ID: 3965060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical efficacy of ticarcillin/clavulanate in severe pneumonia].
    Iakovlev SV; Dvoretskiĭ LI; Shakhova TV
    Antibiot Khimioter; 2000; 45(3):30-4. PubMed ID: 10768064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion of ticarcillin-clavulanate for home treatment of serious infections: clinical efficacy, safety, pharmacokinetics and pharmacodynamics.
    Munckhof WJ; Carney J; Neilson G; Neilson J; Carroll J; McWhinney B; Whitby M
    Int J Antimicrob Agents; 2005 Jun; 25(6):514-22. PubMed ID: 15878264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probable vancomycin-induced neutropenia.
    Segarra-Newnham M; Tagoff SS
    Ann Pharmacother; 2004 Nov; 38(11):1855-9. PubMed ID: 15466904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of ticarcillin in combination with clavulanic acid intravenously and intrauterinely to clinically normal oestrous mares.
    Van Camp SD; Papich MG; Whitacre MD
    J Vet Pharmacol Ther; 2000 Dec; 23(6):373-8. PubMed ID: 11168915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe neutropenia associated with ticarcillin therapy.
    Gastineau D; Spector R; Philips D
    Ann Intern Med; 1981 May; 94(5):711-2. PubMed ID: 7235408
    [No Abstract]   [Full Text] [Related]  

  • 19. Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial.
    Graham DR; Talan DA; Nichols RL; Lucasti C; Corrado M; Morgan N; Fowler CL
    Clin Infect Dis; 2002 Aug; 35(4):381-9. PubMed ID: 12145720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients.
    Dougherty SH; Sirinek KR; Schauer PR; Fink MP; Fabian TC; Martin DH; Wiedermann B
    Am Surg; 1995 Apr; 61(4):297-303. PubMed ID: 7893090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.